English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jan 14, 2026

How geofencing helps retailers link digital ads with real-world store visits
+ Pharmaceuticals
Patient Daily | Jan 14, 2026

Marketers turn to geo-based advertising attribution for improved local campaign insights
+ Pharmaceuticals
Patient Daily | Jan 14, 2026

Calls grow for stronger federal action as US risks losing edge in biotechnology
+ Pharmaceuticals
Patient Daily | Jan 13, 2026

Biotech investors predict active dealmaking and broader focus for 2026
+ Pharmaceuticals
Patient Daily | Jan 13, 2026

Analysts anticipate rebound for biopharma venture capital after late-2025 surge
+ Pharmaceuticals
Patient Daily | Jan 13, 2026

FDA rejects Vanda’s bid for Hetlioz approval in treating jet lag
+ Pharmaceuticals
Patient Daily | Jan 13, 2026

Eli Lilly acquires Ventyx Biosciences for $1.2B; announces cancer therapy pact with InduPro
+ Pharmaceuticals
Patient Daily | Jan 13, 2026

Parabilis secures $305M to advance cancer drug amid biotech fundraising surge

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes